Effect of DMARD Therapy on Inflammatory Biomarkers and Disease Activity in Rheumatoid Arthritis Patients

Effect of DMARD Therapy on Inflammatory Biomarkers and Disease Activity in Rheumatoid Arthritis Patients

Introduction: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by systemic inflammation and joint destruction. Disease-modifying anti-rheumatic drugs (DMARDs) form the cornerstone of RA management, aiming to control disease activity and prevent long-term complications. This st...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hardik Kharbanda, Manish Khanna, Krunal Thakrar, Manojit Basak, Manish Dwivedi, Partha Pratim Das
Format:	Article
Language:	English
Published:	Indian Orthopaedic Research Group 2025-04-01
Series:	Journal of Orthopaedic Case Reports
Subjects:	rheumatoid arthritis disease-modifying anti-rheumatic drugs inflammatory biomarkers disease activity c-reactive protein erythrocyte sedimentation rate disease activity score 28
Online Access:	https://jocr.co.in/wp/2025/04/01/effect-of-dmard-therapy-on-inflammatory-biomarkers-and-disease-activity-in-rheumatoid-arthritis-patients/
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of Ozoralizumab vs. Golimumab for Rheumatoid Arthritis: A Systematic Review
by: Nathania Elma Fithriyah, et al.
Published: (2025-07-01)

Effects of vitamin D supplementation in patients with rheumatoid arthritis: A systematic review and meta-analysis
by: Mahsa Ranjbar, et al.
Published: (2025-02-01)

Expression of two long noncoding ribonucleic acids (growth arrest-specific 5 and H19) in rheumatoid arthritis patients: Relation to clinical characteristics and disease activity
by: Gehan Abdel-Fattah Hegazy, et al.
Published: (2021-01-01)

A Cross-Sectional Study of Depression in Rheumatoid Arthritis Patients at a Tertiary Care Center
by: Hansraj Parmar, et al.
Published: (2025-05-01)

Modern management of rheumatoid arthritis – making a case for early aggressive medical treatment
by: Mohammed Tikly
Published: (2009-08-01)

Leflunomide in disease modifying treatment of rheumatoid arthritis in elderly patients
by: N A Nikitina, et al.
Published: (2008-12-01)

Role of Cathepsin G in Rheumatoid Arthritis Diagnosis and Disease Activity Evaluation
by: Mays Saleh Khamees, et al.
Published: (2024-06-01)

Cross link between monocyte chemotactic protein-1 and rheumatoid arthritis activity and progression
by: Alaa El-Salawy, et al.
Published: (2025-07-01)

Comparative Effects of Combination Therapies; Methotrexate with Leflunomide & Sulfasalazine in the Treatment of Rheumatoid Arthritis
by: Qurrat-ul-Ain Bukhari, et al.
Published: (2017-06-01)

ASSESSMENT OF RHEUMATOID ARTHRITIS ACTIVITY DURING PREGNANCY AND POSTPARTUM
by: E. V. Matyanova, et al.
Published: (2015-04-01)

The Association Between Serum Isthmin-1 and Disease Activity, Inflammation, and Autoantibody Status in Rheumatoid Arthritis
by: Burak Oz, et al.
Published: (2025-05-01)

The anti-inflammatory properties of simvastatin can benefit statin-naïve rheumatoid arthritis patients with associated risks for cardiovascular disease
by: A.O. Komolafe, et al.
Published: (2015-02-01)

A comparison of 3 rheumatoid arthritis disease activity indices in routine clinical practice
by: Amit Kumar Das, et al.
Published: (2017-01-01)

Impact of csDMARDs vs. b/tsDMARDs on the Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multicenter, Retrospective Study
by: Kyung-Ann Lee, et al.
Published: (2025-03-01)

On the application of the “treat-to-target” strategy and the identification of a cohort of difficult-to-treat patients with rheumatoid arthritis in real-world clinical practice
by: O. V. Teplyakova, et al.
Published: (2025-04-01)

COVID-19 and post-covid syndrome in patients with rheumatoid arthritis
by: E. S. Aronova, et al.
Published: (2023-08-01)

Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios Correlation with Rheumatoid Arthritis Disease Activity
by: Noor Hasan Baiee, et al.
Published: (2025-01-01)

PROJECT: RECOMMENDATIONS ON TREATMENT OF RHEUMATOID ARTHRITIS DEVELOPED BY ALL-RUSSIAN PUBLIC ORGANIZATION «ASSOCIATION OF RHEUMATOLOGISTS OF RUSSIA» – 2014 (PART 1)
by: E. L. Nasonov, et al.
Published: (2014-10-01)

PROJECT: RECOMMENDATIONS ON TREATMENT OF RHEUMATOID ARTHRITIS DEVELOPED BY ALL-RUSSIAN PUBLIC ORGANIZATION «ASSOCIATION OF RHEUMATOLOGISTS OF RUSSIA» – 2014 (PART 1)
by: E. L. Nasonov, et al.
Published: (2016-12-01)

PROJECT: RECOMMENDATIONS ON TREATMENT OF RHEUMATOID ARTHRITIS DEVELOPED BY ALL-RUSSIAN PUBLIC ORGANIZATION «ASSOCIATION OF RHEUMATOLOGISTS OF RUSSIA» – 2014 (PART 1)
by: E. L. Nasonov, et al.
Published: (2015-10-01)

The impact of intensive management on pain intensity in patients with rheumatoid arthritis and psoriatic arthritis: secondary analysis of three clinical trials
by: Fowzia Ibrahim, et al.
Published: (2025-05-01)

Chronic Heart Failure in Rheumatoid Arthritis Patients (Part III): Effects of Antirheumatic Drugs
by: D. S. Novikova, et al.
Published: (2020-01-01)

Research progress on complications of rheumatoid arthritis
by: Haiqing Zeng, et al.
Published: (2025-05-01)

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-06-01)

CHANGES IN CALPROTECTIN LEVEL, ITS RELATIONSHIP TO THE CLINICAL AND LABORATORY PARAMETERS OF DISEASE ACTIVITY AND SIGNIFICANCE FOR PREDICTING THE THERAPEUTIC RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ETANERCEPT
by: A. O. Pchelintseva, et al.
Published: (2015-09-01)

The clinical and pathogenetic value of Foxp3+ T regulatory cells in rheumatoid arthritis
by: A. S. Avdeeva, et al.
Published: (2016-10-01)

Comorbid infections in patients with rheumatoid arthritis
by: B.S. Belov
Published: (2014-05-01)

Possible reasons for the inefficacy of genetically engineered biological agents in rheumatoid arthritis and ways of its prevention
by: Natalia Vladimirovna Chichasova
Published: (2012-06-01)

Perioperative Management of Patients with Rheumatic Diseases: Glucocorticoids, DMARDs, Biological Agents and NSAIDs
by: V. V. Lyalina, et al.
Published: (2022-02-01)

Serum adipsin levels in rheumatic diseases: defining its role in disease activity and progression in rheumatoid arthritis and axial spondyloarthritis
by: Marta Novella-Navarro, et al.
Published: (2025-08-01)

DIAGNOSTIC MARKERS AND CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING DMARDS
by: Maria Sergeevna Voronina, et al.
Published: (2012-10-01)

Need to assess the effect of therapy? Ask the patient!
by: E. Yu. Polishchuk, et al.
Published: (2023-06-01)

Course and outcomes of COVID-19 in patients with immunoinflammatory rheumatic diseases: Preliminary data from the NIIR/APP-COVID-19 registry and literature review
by: E. L. Nasonov, et al.
Published: (2021-12-01)

Causal association between diabetes mellitus and rheumatoid arthritis: A bidirectional Mendelian randomization study
by: Zhirong Gu, et al.
Published: (2024-09-01)

Significance of magnetic resonance imaging for early rheumatoid arthritis activity
by: E Y Pogozeva
Published: (2009-02-01)

CHANGES IN THE LEVEL OF FoxP3+ REGULATORY T LYMPHOCYTES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING METHOTREXATE THERAPY
by: A. S. Avdeeva, et al.
Published: (2017-09-01)

Serum calprotectin levels: A measure of disease activity in rheumatoid arthritis
by: Pranshu Dhingra, et al.
Published: (2025-01-01)

An erythrocyte macrocytosis by methotrexate is associated with early initiation of biologic or targeted synthetic agents in patients with rheumatoid arthritis
by: In-Woon Baek, et al.
Published: (2025-01-01)

Relationship between different anti-rheumatic drug therapies and complementary and alternative medicine in patients with rheumatoid arthritis: an interview based cross-sectional study
by: Haya M. Almalag, et al.
Published: (2021-05-01)

EFFICACY AND SAFETY OF SIMVASTATIN IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL, CONTROLLED STUDY
by: I. V. Shirinsky, et al.
Published: (2014-07-01)